0000950170-24-076260.txt : 20240621
0000950170-24-076260.hdr.sgml : 20240621
20240621162002
ACCESSION NUMBER: 0000950170-24-076260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kender Richard N
CENTRAL INDEX KEY: 0001381205
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40657
FILM NUMBER: 241060672
MAIL ADDRESS:
STREET 1: C/O MERCK & CO., INC.
STREET 2: ONE MERCK DRIVE, WS2A-40
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (617) 949-4360
MAIL ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
ownership.xml
4
X0508
4
2024-06-20
0001850838
Omega Therapeutics, Inc.
OMGA
0001381205
Kender Richard N
C/O OMEGA THERAPEUTICS, INC.
140 FIRST STREET, SUITE 501
CAMBRIDGE
MA
02141
true
false
false
false
false
Stock Option (Right to Buy)
2.20
2024-06-20
4
A
false
50000
0.00
A
2034-06-19
Common Stock
50000
50000
D
The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.
/s/ Barbara Chan as Attorney-in-Fact for Richard N. Kender
2024-06-21